On Feb. 27 in Toronto, the 2019 Employers Cancer Care Summit addressed cancer-related concerns tied to benefits plans in the workplace. Here’s what you missed: Gap services one solution to evolving developments in immunotherapy When it comes to cancer treatment, immunotherapy is a game changer with an exciting future ahead, according to Dr. Jeff Rothenstein. […]
Since human papillomavirus can have a significant impact on the health of the working-age population, it’s necessary to talk to patients and employees at to look at the health benefits of vaccines, said Dr. Vivien Brown. Brown, a family physician and vice-president of medical affairs at Medisys Health Group, discussed the current issues and epidemiology of […]
The advisory council on the implementation of national pharmacare has submitted its interim report to the federal government. The report sets out three initial recommendations for the implementation of national pharmacare: Creating a national drug agency to oversee national pharmacare; Developing a comprehensive, evidence-based list of prescribed drugs — a national formulary — to harmonize coverage […]
The Great-West Life Assurance Co. is expanding its coverage of medical cannabis, which includes a new agreement with Shoppers Drug Mart Inc., to deliver its medical cannabis coaching program. “We’ve expanded our optional medical cannabis coverage to our pay-direct drug plans, which represent the vast majority of all of our drug plans, to help the financial, physical […]
Two-thirds (65 per cent) of Canadians would take a drug containing cannabis if it were prescribed by a doctor, approved by Health Canada and covered by insurance, according to a new Ipsos poll. Among the 65 per cent, 36 per cent said they’re very willing and 29 per cent said they’re somewhat willing to do so. Men (69 […]
The Competition Bureau has discontinued an inquiry into allegations that Janssen Inc. inhibited the Canadian market for biosimilar products that compete with its biologic product Remicade. Given the significant impact of biologics in Canada, the report highlights some of the competition issues related to the biologics and biosimilars market. Although the bureau expressed concerns about the […]
While the Ontario Workplace Safety and Insurance Board has traditionally handled medical cannabis on a case-by-case basis, it’s new policy on the drug takes effect on March 1, 2019. The policy, which provides a framework for entitlement to, and approval of, medical cannabis by the WSIB, sets out the following five conditions for entitlement: Neuropathic pain; Spasticity resulting […]
Reformulary Group has signed an agreement with the Great-West Life Assurance Co. to make its managed formulary available to the insurer’s plan sponsors. The formulary was curated with the expert advice of an independent panel of doctors and pharmacists, which reviews research and evidence about drugs. Read: Reformulary Group launches early warning system for high-cost drugs “The […]
Canadians for Fair Access to Medical Marijuana is urging the federal government to remove all taxes on medical cannabis. “More than 480,000 Canadian patients require medical cannabis to help them manage a variety of issues, from chronic pain and arthritis to mental health,” said Gerald Major, president of CFAMM, in a press release. “The government is […]
Allstate Benefits is rolling out its critical illness coverage with medical care support services for Canadian employers and employees. When a plan member is diagnosed with a covered critical illness, they receive a cash benefit based on the percentage payable for that condition. The cash benefit can be used for any example; for instance, to cover […]